Smart Inhalers Market to Expand at a Healthy Growth Rate During the Forecast Period (2019-27)
Market Overview
Market
Research Future (MRFR) says that the Smart Inhalers Market can touch USD 4725.69 Million by 2025.
Meanwhile, the market’s growth rate is expected to be a stunning 45.06% between
appraisal periods.
Get
Sample Report: https://www.marketresearchfuture.com/sample_request/2117
Prominent
Firms
Adherium
(New Zealand), Cohero Health (US), Inspiro Medical (Israel), GlaxoSmithKline
(UK), AstraZeneca (UK), Propeller Health (US), Gecko Health Innovations, Inc
(US), are some of the
leading manufacturers of smart inhalers worldwide.
Primary Boosters and Challenges
Over
the years, smart inhalers have proved to be a game changing invention in the
digital world, emerging as a life savior for many. A smart inhaler works by
connecting to an electronic instrument such as smartphone or PC, where it
directly sends the information and is quite convenient for the user. It is
extensively used by patients facing breathing issues owing to respiratory disease
such as COPD, asthma, fibrosis, ARDS, and others. These issues are the result
of the increase in air pollution in line with the growing emissions of toxic particles
from factories as well as carbon from automobiles. Moreover, increasing
adoption of unhealthy habits such as alcohol consumption and smoking that give
way to pulmonary disorders have also enhanced the market size for smart
inhalers.
Market Segmentation
The
market for smart inhalers has been considered for type, application, and
end-user.
The
key types of smart inhalers are dry powder inhaler as well as metered-dose
inhaler. Metered dose inhalers are the most extensively used devices among asthmatic
patients, since these deliver specific dosage of drugs directly to the lungs,
offering quicker pharmacological action.
Major
applications are asthma, COPD, and others. Smart inhalers’ highest applications
are in asthma, as the cases are escalating worldwide owing to surge in air pollution
levels and the mounting number of smokers.
Hospitals
& clinics, respiratory care centers are some of the top end-users in the
global market. The hospitals and clinics segment should emerge on the top in
the ensuing years.
Regional
Status
The
market for smart inhalers has been regionally distributed into Asia Pacific/APAC,
Americas, MEA or Middle East & Africa and Europe.
The
Americas is on track to take the lead in the global market, given the
substantial rising demand for smart inhalers among the burgeoning patient pool suffering
from diseases such as COPD and asthma. Significant use of the latest
technologies in the healthcare industry combined with the affordability and
benefits of smart inhalers is bound to foster the sales in the forthcoming
years. Country-wise, the highest contribution is made by the US, in view of the
proactive involvement of the leading firms and frequent launches of highly
advanced products.
Europe
can be the second most profitable market in the following years, considering
the substantial contribution of the renowned firms present in the region. Growing
use of latest smart inhalers among patients as well as hospitals could be a key
growth booster. The UK houses the biggest market in the region, thanks to the
vast population of manufacturers present in the country offering extensive
ranges of smart inhalers to a large customer base.
APAC
shall be the fastest advancing market in the coming period, with China and
India expected to be spearheading the growth. Both the countries are densely
populated and are seeing rapid improvement in their healthcare industries,
which is responsible for the market growth. Japan’s nebulizer sector is
thriving, particularly the at home healthcare settings segment. Increasing approvals
along with the escalating adoption rate of latest healthcare technologies favor
the market as well. Soaring cases of asthma and chronic obstructive pulmonary diseases
as well as cancer that requires pulmonary drug administration has also fostered
the demand for smart inhalers in the region.
Latest News
·
October
2020
Zydus Cadila, a renowned drug company
launched a new pressurized metered dose inhaler for COPD (chronic obstructive
pulmonary disease) patients in India. The smart inhaler has been made in-house
using the company’s several innovations with respect to formulation technology.
Browse Full Report: https://www.marketresearchfuture.com/reports/smart-inhalers-market-2117
About
US:
Market
Research Future (MRFR) enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson
Street,5Th Floor, New York,
New York
10013
Related Reports: Hyperhidrosis
Treatment Market Research Report - Global Forecast till 2027
Global
Healthcare Data Storage Market Research Report—Forecast till 2027
Comments
Post a Comment